Informed regulatory decisions are choices made by regulatory bodies such as the FDA, EMA, and other health authorities based on a thorough evaluation of clinical data, safety profiles, and the efficacy of cancer treatments. These decisions aim to ensure that the benefits of a treatment outweigh its risks, providing patients with access to the best possible care.
